We are live on ! Find out more
BHC icon

Bausch Health

368 hedge funds and large institutions have $28.8B invested in Bausch Health in 2013 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 123 increasing their positions, 141 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $356M | Put options by funds: $222M

53% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 30

24% more capital invested

Capital invested by funds: $23.2B → $28.8B (+$5.56B)

3% more funds holding

Funds holding: 356368 (+12)

2% more funds holding in top 10

Funds holding in top 10: 4546 (+1)

1.12% less ownership

Funds ownership: 83.94%82.82% (-1.1%)

13% less repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 141

Holders
368
Holders Change
+12
Holders Change %
+3.37%
% of All Funds
11.93%
Holding in Top 10
46
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+2.22%
% of All Funds
1.49%
New
46
Increased
123
Reduced
141
Closed
30
Calls
$356M
Puts
$222M
Net Calls
+$134M
Net Calls Change
-$12.1M
Name Holding Trade Value Shares
Change
Change in
Stake
NTCOC
101
Northern Trust Company of Connecticut
Connecticut
$20.8M +$88.5K +908 +0.5%
ACP
102
Ashfield Capital Partners
California
$20.7M -$748K -7,675 -4%
Nordea Investment Management
103
Nordea Investment Management
Sweden
$20.3M
OAM
104
Oxford Asset Management
United Kingdom
$20.3M -$706K -7,244 -4%
SC
105
Scotia Capital
Ontario, Canada
$19.7M +$10.7M +109,902 +139%
IIM
106
Intact Investment Management
Quebec, Canada
$18.8M -$12.3M -126,290 -42%
ACM
107
Arrow Capital Management
New York
$18M +$1.46M +15,000 +10%
HHC
108
Hutchin Hill Capital
New York
$17.2M -$21.4M -219,800 -57%
Citadel Advisors
109
Citadel Advisors
Florida
$17M -$11.6M -118,861 -42%
TAM
110
Tocqueville Asset Management
New York
$16.6M -$1.67M -17,150 -10%
TM
111
Tiger Management
New York
$16.4M -$13.8M -142,000 -47%
T
112
TOBAM
France
$16M +$6.16M +63,200 +70%
AA
113
Ancient Art
Texas
$15.8M
Ameriprise
114
Ameriprise
Minnesota
$15.6M -$2.47M -25,405 -15%
Allianz Asset Management
115
Allianz Asset Management
Germany
$15.6M +$3.36M +34,533 +30%
SIIU
116
Scotia Institutional Investments US
Pennsylvania
$15.5M +$2.16M +22,200 +18%
Northern Trust
117
Northern Trust
Illinois
$15M -$139K -1,431 -1%
FDCC
118
Foster Dykema Cabot & Co
Massachusetts
$14.6M -$1.36M -13,950 -9%
CPM
119
Chesapeake Partners Management
Maryland
$14.6M -$9.74M -100,000 -42%
HCMT
120
Highland Capital Management (Texas)
Texas
$14.6M -$3.74M -38,400 -22%
MCG
121
Meru Capital Group
New York
$14.5M +$10.4M +106,466 +325%
O
122
OrbiMed
New York
$14.4M
AII
123
AGF Investments Inc
Ontario, Canada
$13.8M -$838K -8,600 -6%
PAMU
124
Pictet Asset Management (UK)
United Kingdom
$13.5M +$234K +2,400 +2%
Deutsche Bank
125
Deutsche Bank
Germany
$13.3M -$2.57M -26,357 -17%

BHC Hedge Fund Activity: Q3 2013 in Review

368 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2013, worth a combined $28.8B — up 24% from $23.2B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new BHC positions and 30 closed out — a net gain of 16 holders — while 123 added to existing stakes and 141 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $215M. The largest seller was Visium Asset Management, exiting entirely with an estimated $132M sold.

  • 368 institutional investors held Bausch Health (BHC) as of Q3 2013, up from 356 in Q2 2013.
  • Funds reported $28.8B of Bausch Health stock for Q3 2013, up 24% quarter-over-quarter.
  • 46 funds opened new Bausch Health positions in Q3 2013 and 30 closed out, a net change of +16 holders.
  • The largest Bausch Health buyer in Q3 2013 was JP Morgan Chase, an estimated $215M added.
  • The largest Bausch Health seller in Q3 2013 was Visium Asset Management, an estimated $132M sold.

Based on aggregated 13F filings for Q3 2013.